GENOCEA BIOSCIENCES INC (GNCA)
US3724274010 - Common Stock
| MRQ (2022-3-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 20.14M | 37.15M | 79.80M | 40.10M | 26.40M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 4.27M | 4.67M | 2.50M | 1.50M | 700.00K | |||
| Total Current Assets | 24.41M | 41.82M | 82.20M | 41.60M | 27.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 13.50M | 13.26M | 14.40M | 8.90M | 2.60M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 880.00K | 880.00K | 1.80M | 2.10M | 1.50M | |||
| Total Non-Current Assets | 14.38M | 14.15M | 16.30M | 11.00M | 4.00M | |||
| TOTAL ASSETS | 38.79M | 55.97M | 98.50M | 52.60M | 31.10M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 4.70M | 4.64M | 15.50M | 100.00K | 5.30M | |||
| Accrued Expenses | 9.96M | 10.59M | 5.40M | 4.80M | 2.90M | |||
| Accounts Payable | 590.00K | 500.00K | 500.00K | 600.00K | 1.70M | |||
| Other Current Liabilities | 2.77M | 2.95M | 3.60M | 800.00K | 900.00K | |||
| Total Current Liabilities | 18.03M | 18.68M | 25.00M | 6.30M | 10.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 2.95M | 4.15M | 0.00 | 13.40M | 9.60M | |||
| Other Non-Current Liabilities | 5.43M | 6.06M | 64.50M | 7.90M | 3.50M | |||
| Total Non-Current Liabilities | 8.37M | 10.21M | 64.50M | 21.30M | 13.10M | |||
| TOTAL LIABILITIES | 26.40M | 28.89M | 89.50M | 27.60M | 23.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -423.84M | -407.86M | -374.70M | -331.00M | -292.00M | |||
| Additional Paid In Capital | 436.17M | 434.88M | 383.60M | 355.30M | 298.60M | |||
| Common Shares | 60.00K | 60.00K | 100.00K | 700.00K | 800.00K | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 58.73M | 58.23M | 53.00M | 27.50M | 10.80M | |||
| Tangible Book Value per Share | N/A | 0.47 | 0.17 | 0.88 | 0.61 | |||
| Total Shareholders' Equity | 12.38M | 27.07M | 9.00M | 25.00M | 7.30M | |||
| TOTAL LIABILITIES AND EQUITY | 38.79M | 55.97M | 98.50M | 52.60M | 31.10M | |||
| Statistics | ||||||||
| Debt/Equity | 0.24 | 0.15 | N/A | 0.54 | 1.32 | |||
| Current Ratio | 1.35 | 2.24 | 3.29 | 6.60 | 2.53 | |||
| Return On Assets (ROA) | -95.88% | -59.32% | -44.38% | -74.05% | -89.42% | |||
| Return On Equity (ROE) | -300.40% | -122.64% | -485.67% | -155.80% | -380.96% | |||
All data in USD